No connection

Search Results

SERA vs WW

SERA
Sera Prognostics, Inc.
BEARISH
Price
$2.30
Market Cap
$90.0M
Sector
Healthcare
AI Confidence
85%
WW
WW International, Inc.
BEARISH
Price
$9.29
Market Cap
$92.9M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
SERA
--
WW
1.23
Forward P/E
SERA
-3.36
WW
-16.02
P/B Ratio
SERA
1.19
WW
0.29
P/S Ratio
SERA
1111.49
WW
0.13
EV/EBITDA
SERA
-1.49
WW
2.7

Profitability

Gross Margin
SERA
-102.47%
WW
71.72%
Operating Margin
SERA
-89540.0%
WW
-5.38%
Profit Margin
SERA
0.0%
WW
148.6%
ROE
SERA
-51.83%
WW
--
ROA
SERA
-26.15%
WW
6.74%

Growth

Revenue Growth
SERA
-58.3%
WW
-11.7%
Earnings Growth
SERA
--
WW
--

Financial Health

Debt/Equity
SERA
0.03
WW
1.47
Current Ratio
SERA
1.69
WW
1.69
Quick Ratio
SERA
1.62
WW
1.4

Dividends

Dividend Yield
SERA
--
WW
--
Payout Ratio
SERA
0.0%
WW
0.0%

AI Verdict

SERA BEARISH

SERA presents a contradictory profile with a stable Piotroski F-Score of 6/9 but catastrophic operational metrics. While the balance sheet remains lean with very low debt (D/E 0.03) and adequate liquidity, the company is experiencing a severe revenue collapse (-58.3% YoY) and negative gross margins (-102.47%), indicating that the cost of producing its services exceeds the revenue generated. The extreme Price-to-Sales ratio (1111.49) and aggressive insider selling suggest a lack of confidence in the current business model, rendering the single analyst's 'strong buy' rating highly speculative.

Strengths
Low leverage with a Debt/Equity ratio of 0.03
Stable short-term liquidity (Current Ratio 1.69)
Piotroski F-Score of 6/9 indicates stable financial health relative to its own history
Risks
Severe revenue contraction (-58.3% YoY and Q/Q)
Negative gross margins (-102.47%) indicating a non-viable cost structure
Extreme valuation relative to sales (P/S 1111.49)
WW BEARISH

WW presents as a classic value trap; while the Piotroski F-Score is stable (5/9) and the stock trades at a massive discount to its Graham Number ($73.68) and Intrinsic Value ($53.06), the fundamental trajectory is alarming. Revenue is declining (-11.7% YoY), and the forward P/E is negative (-16.02), indicating expected losses. The extreme bearish price momentum (-65.6% over 1 year and -46.6% over 1 month) suggests the market is pricing in a structural decline that deterministic value formulas are failing to capture.

Strengths
Extremely low valuation multiples (P/S 0.13, P/B 0.29)
Strong Gross Margin of 71.72%
Stable Piotroski F-Score of 5/9
Risks
Negative forward earnings expectations (Forward P/E -16.02)
Consistent revenue contraction (-11.7% YoY)
Severe price collapse (-69.4% in 6 months)

Compare Another Pair

SERA vs WW: Head-to-Head Comparison

This page compares Sera Prognostics, Inc. (SERA) and WW International, Inc. (WW) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile